Medicare Program: Application by the Association of Diabetes Care and Education Specialists (ADCES) for Continued CMS Approval of Its Diabetes Outpatient Self-Management Training Program, 53660-53662 [2021-20957]
Download as PDF
53660
Federal Register / Vol. 86, No. 185 / Tuesday, September 28, 2021 / Notices
testing, before travel into the United
States;
• Designated U.S. arrival Ports of
Entry with specific testing operations
and other services for Afghan Evacuees,
which were specifically set up for early
urgent evacuation arrival support, have
been discontinued in the United States;
and
• Evacuees who are still outside of
the United States are in safe locations
where testing can be accessed before
traveling.
Authority: The CDC Director has
issued this Notice authorizing the
rescission of this temporary
humanitarian exemption for individuals
relocating to the United States from
Afghanistan and reimposing the
agency’s Requirement for Negative PreDeparture COVID–19 Test Result
pursuant to Sections 361 of the Public
Health Service Act, 42 U.S.C. 264, and
implementing regulations at 42 CFR
71.20 and 71.31(b).
This Notice is issued to inform the
public of this action.
Sherri Berger,
Chief of Staff, Centers for Disease Control
and Prevention.
[FR Doc. 2021–20987 Filed 9–27–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3413–FN]
Medicare Program: Application by the
Association of Diabetes Care and
Education Specialists (ADCES) for
Continued CMS Approval of Its
Diabetes Outpatient Self-Management
Training Program
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Final notice.
AGENCY:
This final notice announces
our decision to approve the Association
of Diabetes Care and Education
Specialists (ADCES) application for
continued recognition as a national
accrediting organization (AO) for
accrediting entities that wish to furnish
diabetes outpatient self-management
training services to Medicare
beneficiaries.
SUMMARY:
This final notice is effective on
September 27, 2021 through September
27, 2027.
FOR FURTHER INFORMATION CONTACT:
Shannon Freeland, (410) 786–4348.
Caroline Gallaher, (410) 786–8705.
DATES:
VerDate Sep<11>2014
16:35 Sep 27, 2021
Jkt 253001
Lillian Williams, (410) 786–8636.
SUPPLEMENTARY INFORMATION:
I. Background
Diabetes outpatient self-management
training services are defined in section
1861(qq)(1) of the Social Security Act
(the Act) as ‘‘educational and training
services furnished (at such times as the
Secretary determines appropriate) to an
individual with diabetes by a certified
provider (as described in paragraph
(2)(A)) in an outpatient setting by an
individual or entity who meets the
quality standards described in
paragraph (2)(B), but only if the
physician who is managing the
individual’s diabetic condition certifies
that such services are needed under a
comprehensive plan of care related to
the individual’s diabetic condition to
ensure therapy compliance or to provide
the individual with necessary skills and
knowledge (including skills related to
the self-administration of injectable
drugs) to participate in the management
of the individual’s condition.’’
In addition, section 1861(qq)(2)(A) of
the Act describes a ‘‘certified provider’’
as a physician, or other individual or
entity designated by the Secretary of the
Department of Health and Human
Services (the Secretary), that, in
addition to providing diabetes
outpatient self-management training
services, provides other items or
services for which payment may be
made under this title. Section
1861(qq)(2)(B) of the Act further
specifies that a physician, or such other
individual or entity, must meet the
quality standards established by the
Secretary, except that the physician or
other individual or entity shall be
deemed to have met such standards if
the physician or other individual or
entity meets applicable standards
originally established by the National
Diabetes Advisory Board and
subsequently revised by organizations
who participated in the establishment of
standards by such Board or is
recognized by an organization that
represents individuals (including
individuals under this title) with
diabetes as meeting standards for
furnishing the services.
Section 1865 of the Act also permits
the Secretary to use accrediting bodies
to determine whether a provider entity
meets Medicare regulatory quality
standards, such as those established for
diabetes outpatient self-management
training programs. These accrediting
bodies determine whether a diabetes
outpatient self-management training
supplier meets the Medicare regulatory
quality standards established for
diabetes outpatient self-management
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
training service programs. A national
accrediting organization (AO) must be
approved by the Centers for Medicare &
Medicaid Services (CMS) and meet the
standards and requirements specified in
42 CFR part 410, subpart H, to qualify
for Medicare deeming authority.
Our regulations regarding the
application procedures for diabetes
outpatient self-management training
AOs seeking CMS approval are set forth
at 42 CFR 410.142. A national
accreditation organization applying for
deeming authority must provide CMS
with reasonable assurance that it will
require the diabetes outpatient selfmanagement training suppliers it
accredits to meet the CMS’ quality
standards, the National Standards for
Diabetes Self-Management Education
and Support (NSDSMES) standards, or
an alternative set of standards that meet
or exceed our requirements that have
been developed by that AO and that
have been approved by CMS (see 42
CFR 410.144).
Section 410.142(a) of our regulations
states that ‘‘CMS may approve and
recognize a nonprofit organization with
demonstrated experience in
representing the interests of individuals
with diabetes to accredit entities to
furnish training.’’ Therefore, all diabetes
outpatient self-management training
AOs must be not-for-profit
organizations.
Section 410.142(b) of our regulations
require a diabetes outpatient selfmanagement training AO to submit
specific documents and information
with their application, as discussed in
section II of this final notice.
II. Provisions of the Proposed Notice
On April 27, 2021, we published a
proposed notice in the Federal Register
(86 FR 22208) acknowledging receipt of
the Association of Diabetes Care and
Education Specialists (ADCES) request
for continued CMS approval of its
diabetes outpatient self-management
training accreditation program. In that
proposed notice, we detailed our
evaluation criteria.
Under section 1861(qq) of the Act and
our regulations at § 410.142, we
conducted a review of the ADCES’s
diabetes outpatient self-management
training program application using the
criteria specified by our regulations,
which include authorization for CMS to
conduct an onsite visit to verify
information contained in the
organization’s application. For an onsite
visit, the CMS review team travels to the
AO’s corporate office to review specific
information and documents. An onsite
visit is typically part of every
application review. However, due to the
E:\FR\FM\28SEN1.SGM
28SEN1
Federal Register / Vol. 86, No. 185 / Tuesday, September 28, 2021 / Notices
COVID–19 pandemic, it was not
possible for us to conduct an onsite visit
for the ADCES. We conducted our
review virtually, using remote means to
access and review the necessary
information. During this virtual review,
we reviewed documentation including
the ADECS’s: (1) Corporate policies; (2)
financial and human resources records;
(3) policies and procedures, including
those for training, monitoring, and
evaluation of its surveyors and
investigating and responding
appropriately to complaints against
accredited diabetes outpatient selfmanagement training suppliers; and (4)
survey review and decision-making
process for accreditation. This is the
same information that would have been
reviewed during an onsite visit.
Also, as part of our application
review, we reviewed and assessed the
following documents submitted by the
ADCES:
• A detailed comparison including a
crosswalk between the organization’s
standards and the CMS quality
standards described in § 410.144(a).
• Detailed information about the
organization’s accreditation process,
including all of the following
information:
++ Frequency of accreditation.
++ Copies of accreditation forms,
guidelines, and instructions to
evaluators.
++ Descriptions of the following:
—The accreditation review process
and the accreditation status decision
making process.
—The procedures used to notify a
deemed entity of deficiencies in its
diabetes outpatient self-management
training program and procedures to
monitor the correction of those
deficiencies.
—The procedures used to enforce
compliance with the accreditation
requirements and standards.
• Detailed information about the
individuals who perform evaluations for
the organization, including all of the
following information:
++ The education and experience
requirements for the individuals who
perform evaluations.
++ The content and frequency of
continuing education furnished to the
individuals who perform evaluations.
++ The process used to monitor the
performance of individuals who
perform evaluations.
++ The organization’s policies and
practices for participation in the
accreditation process by an individual
who is professionally or financially
affiliated with the entity being
evaluated.
VerDate Sep<11>2014
16:35 Sep 27, 2021
Jkt 253001
• A description of the organization’s
data management and analysis system
for its accreditation activities and
decisions, including the kinds of
reports, tables, and other displays
generated by that system.
• A description of the organization’s
procedures for responding to and
investigating complaints against an
approved entity, including policies and
procedures regarding coordination of
these activities with appropriate
licensing bodies, ombudsmen programs,
and CMS.
• A description of the organization’s
policies and procedures for withholding
or removing a certificate of accreditation
for failure to meet the organization’s
standards or requirements, and other
actions the organization takes in
response to noncompliance with its
standards and requirements.
• A description of all types (for
example, full or partial) and categories
(for example, provisional, conditional,
or temporary) of accreditation offered by
the organization, the duration of each
type and category of accreditation, and
a statement identifying the types and
categories that will serve as a basis for
accreditation if CMS approves the
organization.
• A list of all of the approved entities
currently accredited to furnish training
and the type, category, and expiration
date of the accreditation held by each of
them.
• The name and address of each
person with an ownership or control
interest in the organization.
• Documentation that demonstrates
its ability to furnish CMS with
electronic data in CMS-compatible
format.
• A resource analysis that
demonstrates that its staffing, funding,
and other resources are adequate to
perform the required accreditation
activities.
• A statement acknowledging that, as
a condition for approval and recognition
by CMS of its accreditation program, it
agrees to comply with the requirements
set forth in §§ 410.142 through 410.146.
• Any additional information CMS
requests to enable it to respond to the
organization’s request for CMS approval
and recognition of its accreditation
program to accredit entities to furnish
training.
The April 27, 2021, proposed notice
also solicited public comments
regarding whether the ADCES’s
requirements meet or exceed the
NSDSMES, which are the accreditation
standards used for certification of the
diabetes outpatient self-management
training programs accredited by the
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
53661
ADCES, pursuant to § 410.144(b) and
§ 410.142(e)(1).
III. Analysis of and Responses to Public
Comments on the Proposed Notice
We received six public comments in
response to the April 27, 2021 proposed
notice; however, only one of these
comments were within the scope of the
comment solicitation.
The comment and our response is
addressed below.
Comment: One commenter stated that
diabetes outpatient self-management
training is an evidence-based vital
service for people with diagnosed
diabetes and it has been proven that this
service helps to enhance their clinical
outcomes. The commenter further stated
that it is imperative that the ADCES
continue to offer its services as an AO
for diabetes outpatient self-management
training suppliers.
Response: We thank the commenter
for their support of the CMS diabetes
outpatient self-management training
program and for their recommendation
that the ADCES continue as a CMSapproved diabetes outpatient selfmanagement training AO.
IV. Provisions of the Final Notice
A. Comparison of the ADCES’s
Standards and Requirements for
Accreditation to the NSDSMES and the
Medicare Application Requirements
We compared the ADCES’s diabetes
outpatient self-management training
accreditation requirements and survey
process with the NSDSMES
requirements, and the CMS application
requirements in 42 CFR part 410,
subpart H, as described in section II of
this final notice.
We found the ADCES accreditation
standards and process to be consistent
with the NSDSMES standards and the
CMS requirements.
B. Term of Approval
Based on the review and observations
described in section II of this final
notice, we have determined that the
ADCES’s requirements for diabetes
outpatient self-management training
meet our requirements. Therefore, we
approve the ADCES as a national
accreditation organization for diabetes
outpatient self-management training
programs that request participation in
the Medicare program, effective
September 27, 2021 through September
27, 2027.
V. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting, recordkeeping, or
E:\FR\FM\28SEN1.SGM
28SEN1
53662
Federal Register / Vol. 86, No. 185 / Tuesday, September 28, 2021 / Notices
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
The Administrator of the Centers for
Medicare & Medicaid Services (CMS),
Chiquita Brooks-LaSure, having
reviewed and approved this document,
authorizes Lynette Wilson, who is the
Federal Register Liaison, to
electronically sign this document for
purposes of publication in the Federal
Register.
Dated: September 22, 2021.
Lynette Wilson,
Federal Register Liaison, Centers for Medicare
& Medicaid Services.
[FR Doc. 2021–20957 Filed 9–27–21; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–R–70, CMS–R–
72 and CMS–10783]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
FOR FURTHER INFORMATION CONTACT:
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
November 29, 2021.
SUMMARY:
VerDate Sep<11>2014
16:35 Sep 27, 2021
Jkt 253001
When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: llll, Room C4–
26–05, 7500 Security Boulevard,
Baltimore, Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
ADDRESSES:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–R–70
Information Collection Requirements
in HSQ–110, Acquisition,
Protection and Disclosure of Peer
review Organization Information
and Supporting Regulations
CMS–R–72
Information Collection Requirements
in 42 CFR 478.18, 478.34, 478.36,
478.42, QIO Reconsiderations and
Appeals
CMS–10783
Generic Beneficiary and Family
Centered-Care Quality Improvement
Organization (BFCC–QIO) Data
Collection Research
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Information
Collection Requirements in HSQ–110,
Acquisition, Protection and Disclosure
of Peer review Organization Information
and Supporting Regulations; Use: The
Peer Review Improvement Act of 1982
authorizes quality improvement
organizations (QIOs), formally known as
peer review organizations (PROs), to
acquire information necessary to fulfill
their duties and functions and places
limits on disclosure of the information.
The QIOs are required to provide
notices to the affected parties when
disclosing information about them.
These requirements serve to protect the
rights of the affected parties. The
information provided in these notices is
used by the patients, practitioners and
providers to: Obtain access to the data
maintained and collected on them by
the QIOs; add additional data or make
changes to existing QIO data; and reflect
in the QIO’s record the reasons for the
QIO’s disagreeing with an individual’s
or provider’s request for amendment.
Form Number: CMS–R–70 (OMB control
number: 0938–0426); Frequency:
Reporting—On occasion; Affected
Public: Business or other for-profits;
Number of Respondents: 53,850; Total
Annual Responses: 436,984; Total
Annual Hours: 404,208. (For policy
questions regarding this collection
contact Kimberly Harris at 617–565–
1285.)
2. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Information
Collection Requirements in 42 CFR
478.18, 478.34, 478.36, 478.42, QIO
Reconsiderations and Appeals; Use: In
the event that a beneficiary, provider,
physician, or other practitioner does not
agree with the initial determination of a
Quality Improvement Organization
(QIO) or a QIO subcontractor, it is
within that party’s rights to request
E:\FR\FM\28SEN1.SGM
28SEN1
Agencies
[Federal Register Volume 86, Number 185 (Tuesday, September 28, 2021)]
[Notices]
[Pages 53660-53662]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20957]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3413-FN]
Medicare Program: Application by the Association of Diabetes Care
and Education Specialists (ADCES) for Continued CMS Approval of Its
Diabetes Outpatient Self-Management Training Program
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Final notice.
-----------------------------------------------------------------------
SUMMARY: This final notice announces our decision to approve the
Association of Diabetes Care and Education Specialists (ADCES)
application for continued recognition as a national accrediting
organization (AO) for accrediting entities that wish to furnish
diabetes outpatient self-management training services to Medicare
beneficiaries.
DATES: This final notice is effective on September 27, 2021 through
September 27, 2027.
FOR FURTHER INFORMATION CONTACT:
Shannon Freeland, (410) 786-4348.
Caroline Gallaher, (410) 786-8705.
Lillian Williams, (410) 786-8636.
SUPPLEMENTARY INFORMATION:
I. Background
Diabetes outpatient self-management training services are defined
in section 1861(qq)(1) of the Social Security Act (the Act) as
``educational and training services furnished (at such times as the
Secretary determines appropriate) to an individual with diabetes by a
certified provider (as described in paragraph (2)(A)) in an outpatient
setting by an individual or entity who meets the quality standards
described in paragraph (2)(B), but only if the physician who is
managing the individual's diabetic condition certifies that such
services are needed under a comprehensive plan of care related to the
individual's diabetic condition to ensure therapy compliance or to
provide the individual with necessary skills and knowledge (including
skills related to the self-administration of injectable drugs) to
participate in the management of the individual's condition.''
In addition, section 1861(qq)(2)(A) of the Act describes a
``certified provider'' as a physician, or other individual or entity
designated by the Secretary of the Department of Health and Human
Services (the Secretary), that, in addition to providing diabetes
outpatient self-management training services, provides other items or
services for which payment may be made under this title. Section
1861(qq)(2)(B) of the Act further specifies that a physician, or such
other individual or entity, must meet the quality standards established
by the Secretary, except that the physician or other individual or
entity shall be deemed to have met such standards if the physician or
other individual or entity meets applicable standards originally
established by the National Diabetes Advisory Board and subsequently
revised by organizations who participated in the establishment of
standards by such Board or is recognized by an organization that
represents individuals (including individuals under this title) with
diabetes as meeting standards for furnishing the services.
Section 1865 of the Act also permits the Secretary to use
accrediting bodies to determine whether a provider entity meets
Medicare regulatory quality standards, such as those established for
diabetes outpatient self-management training programs. These
accrediting bodies determine whether a diabetes outpatient self-
management training supplier meets the Medicare regulatory quality
standards established for diabetes outpatient self-management training
service programs. A national accrediting organization (AO) must be
approved by the Centers for Medicare & Medicaid Services (CMS) and meet
the standards and requirements specified in 42 CFR part 410, subpart H,
to qualify for Medicare deeming authority.
Our regulations regarding the application procedures for diabetes
outpatient self-management training AOs seeking CMS approval are set
forth at 42 CFR 410.142. A national accreditation organization applying
for deeming authority must provide CMS with reasonable assurance that
it will require the diabetes outpatient self-management training
suppliers it accredits to meet the CMS' quality standards, the National
Standards for Diabetes Self-Management Education and Support (NSDSMES)
standards, or an alternative set of standards that meet or exceed our
requirements that have been developed by that AO and that have been
approved by CMS (see 42 CFR 410.144).
Section 410.142(a) of our regulations states that ``CMS may approve
and recognize a nonprofit organization with demonstrated experience in
representing the interests of individuals with diabetes to accredit
entities to furnish training.'' Therefore, all diabetes outpatient
self-management training AOs must be not-for-profit organizations.
Section 410.142(b) of our regulations require a diabetes outpatient
self-management training AO to submit specific documents and
information with their application, as discussed in section II of this
final notice.
II. Provisions of the Proposed Notice
On April 27, 2021, we published a proposed notice in the Federal
Register (86 FR 22208) acknowledging receipt of the Association of
Diabetes Care and Education Specialists (ADCES) request for continued
CMS approval of its diabetes outpatient self-management training
accreditation program. In that proposed notice, we detailed our
evaluation criteria.
Under section 1861(qq) of the Act and our regulations at Sec.
410.142, we conducted a review of the ADCES's diabetes outpatient self-
management training program application using the criteria specified by
our regulations, which include authorization for CMS to conduct an
onsite visit to verify information contained in the organization's
application. For an onsite visit, the CMS review team travels to the
AO's corporate office to review specific information and documents. An
onsite visit is typically part of every application review. However,
due to the
[[Page 53661]]
COVID-19 pandemic, it was not possible for us to conduct an onsite
visit for the ADCES. We conducted our review virtually, using remote
means to access and review the necessary information. During this
virtual review, we reviewed documentation including the ADECS's: (1)
Corporate policies; (2) financial and human resources records; (3)
policies and procedures, including those for training, monitoring, and
evaluation of its surveyors and investigating and responding
appropriately to complaints against accredited diabetes outpatient
self-management training suppliers; and (4) survey review and decision-
making process for accreditation. This is the same information that
would have been reviewed during an onsite visit.
Also, as part of our application review, we reviewed and assessed
the following documents submitted by the ADCES:
A detailed comparison including a crosswalk between the
organization's standards and the CMS quality standards described in
Sec. 410.144(a).
Detailed information about the organization's
accreditation process, including all of the following information:
++ Frequency of accreditation.
++ Copies of accreditation forms, guidelines, and instructions to
evaluators.
++ Descriptions of the following:
--The accreditation review process and the accreditation status
decision making process.
--The procedures used to notify a deemed entity of deficiencies in
its diabetes outpatient self-management training program and procedures
to monitor the correction of those deficiencies.
--The procedures used to enforce compliance with the accreditation
requirements and standards.
Detailed information about the individuals who perform
evaluations for the organization, including all of the following
information:
++ The education and experience requirements for the individuals
who perform evaluations.
++ The content and frequency of continuing education furnished to
the individuals who perform evaluations.
++ The process used to monitor the performance of individuals who
perform evaluations.
++ The organization's policies and practices for participation in
the accreditation process by an individual who is professionally or
financially affiliated with the entity being evaluated.
A description of the organization's data management and
analysis system for its accreditation activities and decisions,
including the kinds of reports, tables, and other displays generated by
that system.
A description of the organization's procedures for
responding to and investigating complaints against an approved entity,
including policies and procedures regarding coordination of these
activities with appropriate licensing bodies, ombudsmen programs, and
CMS.
A description of the organization's policies and
procedures for withholding or removing a certificate of accreditation
for failure to meet the organization's standards or requirements, and
other actions the organization takes in response to noncompliance with
its standards and requirements.
A description of all types (for example, full or partial)
and categories (for example, provisional, conditional, or temporary) of
accreditation offered by the organization, the duration of each type
and category of accreditation, and a statement identifying the types
and categories that will serve as a basis for accreditation if CMS
approves the organization.
A list of all of the approved entities currently
accredited to furnish training and the type, category, and expiration
date of the accreditation held by each of them.
The name and address of each person with an ownership or
control interest in the organization.
Documentation that demonstrates its ability to furnish CMS
with electronic data in CMS-compatible format.
A resource analysis that demonstrates that its staffing,
funding, and other resources are adequate to perform the required
accreditation activities.
A statement acknowledging that, as a condition for
approval and recognition by CMS of its accreditation program, it agrees
to comply with the requirements set forth in Sec. Sec. 410.142 through
410.146.
Any additional information CMS requests to enable it to
respond to the organization's request for CMS approval and recognition
of its accreditation program to accredit entities to furnish training.
The April 27, 2021, proposed notice also solicited public comments
regarding whether the ADCES's requirements meet or exceed the NSDSMES,
which are the accreditation standards used for certification of the
diabetes outpatient self-management training programs accredited by the
ADCES, pursuant to Sec. 410.144(b) and Sec. 410.142(e)(1).
III. Analysis of and Responses to Public Comments on the Proposed
Notice
We received six public comments in response to the April 27, 2021
proposed notice; however, only one of these comments were within the
scope of the comment solicitation.
The comment and our response is addressed below.
Comment: One commenter stated that diabetes outpatient self-
management training is an evidence-based vital service for people with
diagnosed diabetes and it has been proven that this service helps to
enhance their clinical outcomes. The commenter further stated that it
is imperative that the ADCES continue to offer its services as an AO
for diabetes outpatient self-management training suppliers.
Response: We thank the commenter for their support of the CMS
diabetes outpatient self-management training program and for their
recommendation that the ADCES continue as a CMS-approved diabetes
outpatient self-management training AO.
IV. Provisions of the Final Notice
A. Comparison of the ADCES's Standards and Requirements for
Accreditation to the NSDSMES and the Medicare Application Requirements
We compared the ADCES's diabetes outpatient self-management
training accreditation requirements and survey process with the NSDSMES
requirements, and the CMS application requirements in 42 CFR part 410,
subpart H, as described in section II of this final notice.
We found the ADCES accreditation standards and process to be
consistent with the NSDSMES standards and the CMS requirements.
B. Term of Approval
Based on the review and observations described in section II of
this final notice, we have determined that the ADCES's requirements for
diabetes outpatient self-management training meet our requirements.
Therefore, we approve the ADCES as a national accreditation
organization for diabetes outpatient self-management training programs
that request participation in the Medicare program, effective September
27, 2021 through September 27, 2027.
V. Collection of Information Requirements
This document does not impose information collection requirements,
that is, reporting, recordkeeping, or
[[Page 53662]]
third-party disclosure requirements. Consequently, there is no need for
review by the Office of Management and Budget under the authority of
the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.).
The Administrator of the Centers for Medicare & Medicaid Services
(CMS), Chiquita Brooks-LaSure, having reviewed and approved this
document, authorizes Lynette Wilson, who is the Federal Register
Liaison, to electronically sign this document for purposes of
publication in the Federal Register.
Dated: September 22, 2021.
Lynette Wilson,
Federal Register Liaison, Centers for Medicare & Medicaid Services.
[FR Doc. 2021-20957 Filed 9-27-21; 8:45 am]
BILLING CODE 4120-01-P